Edwards Lifesciences
690 hedge funds and large institutions have $16.6B invested in Edwards Lifesciences in 2017 Q1 according to their latest regulatory filings, with 99 funds opening new positions, 206 increasing their positions, 284 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
27% less repeat investments, than reductions
Existing positions increased: 206 | Existing positions reduced: 284
34% less call options, than puts
Call options by funds: $71.2M | Put options by funds: $107M
50% less funds holding in top 10
Funds holding in top 10: 14 → 7 (-7)
Holders
690
Holding in Top 10
7
Calls
$71.2M
Puts
$107M
Top Buyers
| 1 | +$1.26B | |
| 2 | +$228M | |
| 3 | +$137M | |
| 4 |
HM
HealthCor Management
New York
|
+$118M |
| 5 |
WP
Wedgewood Partners
St Louis,
Missouri
|
+$107M |
Top Sellers
| 1 | -$497M | |
| 2 | -$347M | |
| 3 | -$126M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$89.8M |
| 5 |
CCI
Columbus Circle Investors
|
-$83.6M |